Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 06 Oct 2021 – 20 Aug 2026, limited by Kotak Multicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Multicap Fund | Nifty 500 |
|---|---|---|
| 06 Oct 2021 | ₹100.00 | ₹100.00 |
| 03 Mar 2022 | ₹90.37 | ₹93.40 |
| 30 Jul 2022 | ₹97.12 | ₹96.90 |
| 25 Dec 2022 | ₹102.66 | ₹99.41 |
| 22 May 2023 | ₹107.98 | ₹102.44 |
| 17 Oct 2023 | ₹132.70 | ₹115.42 |
| 14 Mar 2024 | ₹158.36 | ₹131.60 |
| 09 Aug 2024 | ₹188.90 | ₹151.46 |
| 04 Jan 2025 | ₹192.24 | ₹150.04 |
| 01 Jun 2025 | ₹184.53 | ₹150.66 |
| 28 Oct 2025 | ₹200.64 | ₹157.34 |
| 25 Mar 2026 | ₹183.09 | ₹141.92 |
| 20 Aug 2026 | ₹202.88 | ₹155.36 |
| Metric | Kotak Mahindra · Regular NAV ₹20.31 Very High risk ★★★★☆ | Category median Multi Cap Fund · 33 funds |
|---|---|---|
| +6.55% | +8.06% | |
| +17.76% | +15.20% | |
| — | +14.26% | |
| — | +14.26% | |
| +15.63% | +14.72% | |
| +16.42% | — | |
| +23.06% | +16.83% | |
| — | +15.79% | |
| — | +14.87% | |
| Risk | ||
| 16.05% | 14.84% | |
| 0.70 | 0.56 | |
| 0.95 | 0.76 | |
| -21.42% | -20.32% | |
| Nifty 500 | — | |
| +4.56% | +2.81% | |
| 1.11 | 1.01 | |
| 122.3% | 110.1% | |
| 105.3% | 95.9% | |
| 1.83% | 2.21% | |
| ₹25,937Cr | ₹3,513Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹2.02K | — | |
| ₹100 | — | |
| 45% | 56% | |
| Abhishek Bisen | — | |
| 06 Oct 2021 | — | |
| 74 | — | |
| 32.6% | — | |
| 2.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.